Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 3Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Completed 11Recruiting 5Unknown 2Terminated 2

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 2Lymphoid 1Gynecologic 1

Conditions

Breast Neoplasms 311Carcinoma, Non-Small-Cell Lung 282Prostatic Neoplasms 160Colorectal Neoplasms 155Carcinoma, Hepatocellular 144Neoplasms 134Leukemia, Myeloid, Acute 132Lung Neoplasms 115Squamous Cell Carcinoma of Head and Neck 108Triple Negative Breast Neoplasms 102Multiple Myeloma 102Recurrence 99Pancreatic Neoplasms 94Stomach Neoplasms 93Ovarian Neoplasms 87Neoplasm Metastasis 87Lymphoma, Large B-Cell, Diffuse 81Sarcoma 70Precursor Cell Lymphoblastic Leukemia-Lymphoma 68Esophageal Neoplasms 67Uterine Cervical Neoplasms 66Melanoma 65Brain Neoplasms 65Rectal Neoplasms 62Head and Neck Neoplasms 62Glioblastoma 60Carcinoma, Renal Cell 57Lymphoma 55Myelodysplastic Syndromes 54Esophageal Squamous Cell Carcinoma 54

Interventions

isatuximab 1gallium 68 PSMA-11 1Pluvicto 1Gemcitabine 1Eplerenone 1Dexamethasone 1Cyclophosphamide 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Renal Insufficiency × Clear all
NCT07489534 2026-03-24

Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction

Chinese PLA General Hospital

Phase 2 Recruiting
25 enrolled
Plasma cell

Multiple Myeloma, Renal Insufficiency

NCT06004661 2026-03-06

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Novartis

Phase 2 Recruiting
20 enrolled

Renal Insufficiency

NCT07029503 2026-02-24

SCARF-1

Karolinska Institutet

Phase 2 Recruiting
40 enrolled
Lymphoid

Heart Failure, Lymphoma, Follicular, Renal Insufficiency, Chronic, Renal Insufficiency

NCT04240054 2026-01-28

VICD

Medical College of Wisconsin

Phase 2 Recruiting
41 enrolled
Plasma cell

Multiple Myeloma, Renal Insufficiency

NCT03101995 2025-05-28

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

National Institute of Cancerología

Phase 2 Recruiting
18 enrolled
Gynecologic

Uterine Cervical Neoplasms, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡